Antileukotrienes for the prevention and treatment of chronic lung disease in very preterm newborns: a systematic review.

Use of antileukotrienes in very preterm infants to prevent or treat chronic lung disease is not supported by the available evidence. Large randomized trials focusing on outcomes relevant to patients, including long-term outcomes, are needed. Studies should also minimize risk of bias.